Abacavir Tablet, Film Coated
Product Images NDC 65862-073

2 FDA label images from Aurobindo Pharma Limited · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Abacavir (NDC 65862-073). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (300 mg (60 Tablet Bottle))

Package Label-principal Display Panel (300 mg (60 Tablet Bottle))
Label for Abacavir Tablets USP 300 mg, film-coated tablets distributed by Aurobindo Pharma USA, Inc. The label specifies a package of 60 tablets, includes storage instructions, dosage guidance to refer to the package insert, and a note for authorized dispensers regarding Medication Guide and Warning Card. It also displays a barcode and the product NDC 65862-073-60.*
FDA Label Image

Chemical Structure (Abacavir Str)

Chemical Structure (Abacavir Str)
Chemical structure of Abacavir, showing its molecular arrangement including a cyclopropyl group, purine base, and an attached hydroxymethyl group, with an associated sulfate salt (H2SO4) component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.